世界の免疫調節剤市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV01555)
◆英語タイトル:Global Immunomodulators Market Insights and Forecast to 2026
◆商品コード:QYR20NV01555
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは免疫調節剤の世界市場について調査・分析した資料です。種類別(免疫抑制剤、免疫賦活剤)の市場規模、用途別(腫瘍学、呼吸器、HIV、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別免疫調節剤の競争状況、市場シェア
・世界の免疫調節剤市場:種類別市場規模 2015年-2020年(免疫抑制剤、免疫賦活剤)
・世界の免疫調節剤市場:種類別市場規模予測 2021年-2026年(免疫抑制剤、免疫賦活剤)
・世界の免疫調節剤市場:用途別市場規模 2015年-2020年(腫瘍学、呼吸器、HIV、その他)
・世界の免疫調節剤市場:用途別市場規模予測 2021年-2026年(腫瘍学、呼吸器、HIV、その他)
・北米の免疫調節剤市場分析:米国、カナダ
・ヨーロッパの免疫調節剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの免疫調節剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の免疫調節剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの免疫調節剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Roche、Amgen Inc.、Abbott、Johnson & Johnson、Novartis AG、Eli Lilly and Company、Bristol-Myers Squibb Company、Merck & Co. Inc.、Biogen
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Immunomodulators are referred to as the medications that are used for the regulation or for normalizing the immune system.
The global market for immunomodualtors is expected to grow exponentially over the forecast period owing to the rising cases of chronic diseases such as multiple sclerosis, allergic conditions, cancer, and asthma.

Market Analysis and Insights: Global Immunomodulators Market
The global Immunomodulators market size is projected to reach US$ 141150 million by 2026, from US$ 136630 million in 2020, at a CAGR of 3.1%% during 2021-2026.

Global Immunomodulators Scope and Market Size
Immunomodulators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunomodulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Immunomodulators market is segmented into
Immunosuppressant
Immunostimulants

Segment by Application, the Immunomodulators market is segmented into
Oncology
Respiratory
HIV
Others

Regional and Country-level Analysis
The Immunomodulators market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunomodulators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunomodulators Market Share Analysis
Immunomodulators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunomodulators business, the date to enter into the Immunomodulators market, Immunomodulators product introduction, recent developments, etc.

The major vendors covered:
Roche
Amgen Inc.
Abbott
Johnson & Johnson
Novartis AG
Eli Lilly and Company
Bristol-Myers Squibb Company
Merck & Co. Inc.
Biogen

【レポートの目次】

1 Study Coverage
1.1 Immunomodulators Product Introduction
1.2 Market Segments
1.3 Key Immunomodulators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunomodulators Market Size Growth Rate by Type
1.4.2 Immunosuppressant
1.4.3 Immunostimulants
1.5 Market by Application
1.5.1 Global Immunomodulators Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Respiratory
1.5.4 HIV
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Immunomodulators Market Size, Estimates and Forecasts
2.1.1 Global Immunomodulators Revenue 2015-2026
2.1.2 Global Immunomodulators Sales 2015-2026
2.2 Global Immunomodulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunomodulators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunomodulators Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Immunomodulators Competitor Landscape by Players
3.1 Immunomodulators Sales by Manufacturers
3.1.1 Immunomodulators Sales by Manufacturers (2015-2020)
3.1.2 Immunomodulators Sales Market Share by Manufacturers (2015-2020)
3.2 Immunomodulators Revenue by Manufacturers
3.2.1 Immunomodulators Revenue by Manufacturers (2015-2020)
3.2.2 Immunomodulators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunomodulators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunomodulators Revenue in 2019
3.2.5 Global Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunomodulators Price by Manufacturers
3.4 Immunomodulators Manufacturing Base Distribution, Product Types
3.4.1 Immunomodulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunomodulators Product Type
3.4.3 Date of International Manufacturers Enter into Immunomodulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Immunomodulators Market Size by Type (2015-2020)
4.1.1 Global Immunomodulators Sales by Type (2015-2020)
4.1.2 Global Immunomodulators Revenue by Type (2015-2020)
4.1.3 Immunomodulators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunomodulators Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunomodulators Sales Forecast by Type (2021-2026)
4.2.2 Global Immunomodulators Revenue Forecast by Type (2021-2026)
4.2.3 Immunomodulators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunomodulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Immunomodulators Market Size by Application (2015-2020)
5.1.1 Global Immunomodulators Sales by Application (2015-2020)
5.1.2 Global Immunomodulators Revenue by Application (2015-2020)
5.1.3 Immunomodulators Price by Application (2015-2020)
5.2 Immunomodulators Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunomodulators Sales Forecast by Application (2021-2026)
5.2.2 Global Immunomodulators Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunomodulators Price Forecast by Application (2021-2026)

6 North America
6.1 North America Immunomodulators by Country
6.1.1 North America Immunomodulators Sales by Country
6.1.2 North America Immunomodulators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunomodulators Market Facts & Figures by Type
6.3 North America Immunomodulators Market Facts & Figures by Application

7 Europe
7.1 Europe Immunomodulators by Country
7.1.1 Europe Immunomodulators Sales by Country
7.1.2 Europe Immunomodulators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunomodulators Market Facts & Figures by Type
7.3 Europe Immunomodulators Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Immunomodulators by Region
8.1.1 Asia Pacific Immunomodulators Sales by Region
8.1.2 Asia Pacific Immunomodulators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunomodulators Market Facts & Figures by Type
8.3 Asia Pacific Immunomodulators Market Facts & Figures by Application

9 Latin America
9.1 Latin America Immunomodulators by Country
9.1.1 Latin America Immunomodulators Sales by Country
9.1.2 Latin America Immunomodulators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunomodulators Market Facts & Figures by Type
9.3 Central & South America Immunomodulators Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Immunomodulators by Country
10.1.1 Middle East and Africa Immunomodulators Sales by Country
10.1.2 Middle East and Africa Immunomodulators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunomodulators Market Facts & Figures by Type
10.3 Middle East and Africa Immunomodulators Market Facts & Figures by Application

11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Immunomodulators Products Offered
11.1.5 Roche Related Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Description and Business Overview
11.2.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc. Immunomodulators Products Offered
11.2.5 Amgen Inc. Related Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Description and Business Overview
11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Immunomodulators Products Offered
11.3.5 Abbott Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Immunomodulators Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Description and Business Overview
11.5.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG Immunomodulators Products Offered
11.5.5 Novartis AG Related Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Description and Business Overview
11.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly and Company Immunomodulators Products Offered
11.6.5 Eli Lilly and Company Related Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Corporation Information
11.7.2 Bristol-Myers Squibb Company Description and Business Overview
11.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Company Immunomodulators Products Offered
11.7.5 Bristol-Myers Squibb Company Related Developments
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Corporation Information
11.8.2 Merck & Co. Inc. Description and Business Overview
11.8.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Inc. Immunomodulators Products Offered
11.8.5 Merck & Co. Inc. Related Developments
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description and Business Overview
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Immunomodulators Products Offered
11.9.5 Biogen Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Immunomodulators Products Offered
11.1.5 Roche Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunomodulators Market Estimates and Projections by Region
12.1.1 Global Immunomodulators Sales Forecast by Regions 2021-2026
12.1.2 Global Immunomodulators Revenue Forecast by Regions 2021-2026
12.2 North America Immunomodulators Market Size Forecast (2021-2026)
12.2.1 North America: Immunomodulators Sales Forecast (2021-2026)
12.2.2 North America: Immunomodulators Revenue Forecast (2021-2026)
12.2.3 North America: Immunomodulators Market Size Forecast by Country (2021-2026)
12.3 Europe Immunomodulators Market Size Forecast (2021-2026)
12.3.1 Europe: Immunomodulators Sales Forecast (2021-2026)
12.3.2 Europe: Immunomodulators Revenue Forecast (2021-2026)
12.3.3 Europe: Immunomodulators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunomodulators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunomodulators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunomodulators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunomodulators Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunomodulators Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunomodulators Sales Forecast (2021-2026)
12.5.2 Latin America: Immunomodulators Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunomodulators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunomodulators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunomodulators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunomodulators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunomodulators Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunomodulators Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunomodulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Roche、Amgen Inc.、Abbott、Johnson & Johnson、Novartis AG、Eli Lilly and Company、Bristol-Myers Squibb Company、Merck & Co. Inc.、Biogen

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の免疫調節剤市場2026:インサイト・予測(Global Immunomodulators Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。